Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision, v3.5.5, was added to the record history, replacing the previous v3.5.4. This reflects an update to the page’s revision-tracking version within ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-06-09T02:27:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.5.4, was added to the Record History for the study page. The previous revision, v3.5.3, is no longer current in the visible history.
    Difference
    0.1%
    Check dated 2026-05-18T13:30:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s displayed revision identifier changes from v3.5.2 to v3.5.3, indicating a site/version update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-27T07:47:16.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T04:54:33.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Release note added for site version v3.5.0 in the record history. The previous version v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-22T09:23:40.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.4.3 and removed the v3.4.2 entry in the study record's history.
    Difference
    0.1%
    Check dated 2026-03-08T02:32:49.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.